Navidea Biopharmaceuticals, Inc. (NAVB): Price and Financial Metrics
NAVB Price/Volume Stats
| Current price | $0.04 | 52-week high | $0.34 |
| Prev. close | $0.04 | 52-week low | $0.02 |
| Day low | $0.04 | Volume | 74,100 |
| Day high | $0.04 | Avg. volume | 137,796 |
| 50-day MA | $0.06 | Dividend yield | N/A |
| 200-day MA | $0.08 | Market Cap | 3.72M |
NAVB Stock Price Chart Interactive Chart >
Navidea Biopharmaceuticals, Inc. (NAVB) Company Bio
Navidea Biopharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision radiopharmaceutical diagnostics for diseases such as cancer.
Latest NAVB News From Around the Web
Below are the latest news stories about NAVIDEA BIOPHARMACEUTICALS INC that investors may wish to consider to help them evaluate NAVB as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayPre-market stock movers are a hot topic on Tuesday as investors seek out the latest news on the biggest gainers and losers this morning! |
Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing PanelDUBLIN, Ohio, August 10, 2023--Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel |
Why Is Navidea Biopharmaceutical (NAVB) Stock Down 13% Today?Navidea Biopharmaceutical (NAVB) stock is falling on Monday after the biopharmaceutical company got a major delisting warning. |
Why Is SOFI Stock Up 19% Today?SoFi Technologies (SOFI) stock is on the rise Monday after the financial services company released results for the second quarter of 2023. |
Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?Sonnet BioTherapeutics (SONN) stock is taking a beating on Monday after the company announced details for a public stock offering. |
NAVB Price Returns
| 1-mo | -25.79% |
| 3-mo | -20.00% |
| 6-mo | -46.67% |
| 1-year | -87.69% |
| 3-year | -98.58% |
| 5-year | -98.65% |
| YTD | -27.54% |
| 2023 | -73.71% |
| 2022 | -79.00% |
| 2021 | -53.49% |
| 2020 | 70.63% |
| 2019 | -37.00% |
Continue Researching NAVB
Here are a few links from around the web to help you further your research on Navidea Biopharmaceuticals Inc's stock as an investment opportunity:Navidea Biopharmaceuticals Inc (NAVB) Stock Price | Nasdaq
Navidea Biopharmaceuticals Inc (NAVB) Stock Quote, History and News - Yahoo Finance
Navidea Biopharmaceuticals Inc (NAVB) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...